Estimating rate of lung function change using clinical spirometry data.


Journal

BMJ open respiratory research
ISSN: 2052-4439
Titre abrégé: BMJ Open Respir Res
Pays: England
ID NLM: 101638061

Informations de publication

Date de publication:
03 Oct 2024
Historique:
received: 19 06 2023
accepted: 10 09 2024
medline: 4 10 2024
pubmed: 4 10 2024
entrez: 3 10 2024
Statut: epublish

Résumé

In chronic obstructive pulmonary disease (COPD), accurately estimating lung function from electronic health record (EHR) data would be beneficial but requires addressing complexities in clinically obtained testing. This study compared analytic methods for estimating rate of forced expiratory volume in one second (FEV We estimated rate of FEV Among 1417 participants, median rate of change was approximately -30 mL/year or -2%/year. Non-regressive methods frequently generated erroneous estimates due to outlier first measurements or short intervals between tests. Average change yielded the most extreme estimates (minimum=-3761 mL/year), while regressive methods, and Huber specifically, minimised extreme estimates. Huber, Total Change and Quantile FEV Using EHR data to estimate FEV

Identifiants

pubmed: 39362797
pii: 11/1/e001896
doi: 10.1136/bmjresp-2023-001896
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Aparna Balasubramanian (A)

Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, USA abalasu2@jhmi.edu.

Christopher Cervantes (C)

Asymmetric Operations Sector, Johns Hopkins University Applied Physics Laboratory, Laurel, Maryland, USA.

Andrew S Gearhart (AS)

Research and Exploratory Development Department, Johns Hopkins University Applied Physics Laboratory, Laurel, Maryland, USA.

Nirupama Putcha (N)

Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, USA.

Ashraf Fawzy (A)

Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, USA.

Meredith C McCormack (MC)

Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, USA.

Anil Singh (A)

Pulmonary and Critical Care Medicine, Alleghany Health Network, Pittsburgh, Pennsylvania, USA.

Robert A Wise (RA)

Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, USA.

Nadia N Hansel (NN)

Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH